Literature DB >> 279299

Pharmacokinetics of liposome-encapsulated antitumor drugs and implications for therapy.

R L Juliano, D Stamp, N McCullough.   

Abstract

Mesh：

Substances：

Year:  1978        PMID： 279299     DOI： 10.1111/j.1749-6632.1978.tb22038.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  9 in total

1.  Pleiotropic effects of positively charged liposomes on immune functions.

Authors:  H M Thérien; J Gruda
Journal:  In Vitro Cell Dev Biol       Date:  1990-05

2.  Porous biodegradable microspheres for controlled drug delivery. I. Assessment of processing conditions and solvent removal techniques.

Authors:  T Sato; M Kanke; H G Schroeder; P P DeLuca
Journal:  Pharm Res       Date:  1988-01       Impact factor: 4.200

Review 3.  Immunoglobulins as targeting agents for liposome encapsulated drugs.

Authors:  P A Toonen; D J Crommelin
Journal:  Pharm Weekbl Sci       Date:  1983-12-16

4.  Factors influencing the enhanced hypocalcemic action of liposome-entrapped calcitonin.

Authors:  M Fukunaga; M M Miller; L J Deftos
Journal:  Calcif Tissue Int       Date:  1990-12       Impact factor: 4.333

5.  Altered pharmacological properties of liposome-associated human interferon-alpha.

Authors:  D A Eppstein; W E Stewart
Journal:  J Virol       Date:  1982-02       Impact factor: 5.103

6.  Multimodal Nanocarrier Probes Reveal Superior Biodistribution Quantification by Isotopic Analysis over Fluorescence.

Authors:  Hongping Deng; Christian J Konopka; Tzu-Wen L Cross; Kelly S Swanson; Lawrence W Dobrucki; Andrew M Smith
Journal:  ACS Nano       Date:  2020-01-07       Impact factor: 15.881

7.  Effective encapsulation and biological activity of phosphorylated chemotherapeutics in calcium phosphosilicate nanoparticles for the treatment of pancreatic cancer.

Authors:  Welley S Loc; Samuel S Linton; Zachary R Wilczynski; Gail L Matters; Christopher O McGovern; Thomas Abraham; Todd Fox; Christopher M Gigliotti; Xiaomeng Tang; Amra Tabakovic; Jo Ann Martin; Gary A Clawson; Jill P Smith; Peter J Butler; Mark Kester; James H Adair
Journal:  Nanomedicine       Date:  2017-07-01       Impact factor: 5.307

8.  Immunotoxicity of multiple dosing regimens of free doxorubicin and doxorubicin entrapped in cardiolipin liposomes.

Authors:  A Rahman; A Joher; J R Neefe
Journal:  Br J Cancer       Date:  1986-09       Impact factor: 7.640

9.  Pharmacokinetics of a liposomal formulation of doxorubicin in rats.

Authors:  Zongyu Liu; Ye Bi; Yating Sun; Fei Hao; Jiahui Lu; Qingfan Meng; Robert J Lee; Yaping Tian; Jing Xie
Journal:  Saudi Pharm J       Date:  2017-05-13       Impact factor: 4.330
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.